VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar HIGHG33K (72.23) Submitted: 7/13/2012 8:39:49 PM : Outperform Start Price: $27.55 VVUS Score: -73.44

FDA approval is inevitable.

Featured Broker Partners


Advertisement